Apt Medical688617.SHValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Apt Medical (688617.SH) trades at a P/E of 37.80x, P/B of 11.40x, P/S of 11.60x, and a dividend yield of 0.39%.
Longitudinal percentile comparison: P/E sits at the 10th percentile over the trailing 10Y window (vs. 18th percentile over 3Y); P/B sits at the 31st percentile over the trailing 10Y window (vs. 27th percentile over 3Y); P/S sits at the 12th percentile over the trailing 10Y window (vs. 18th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 50th percentile within its industry and the 51st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.68%, ranking at the 73rd percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 21.1 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 0.68% total shareholder yield, 0.39% is paid out as dividends and roughly 0.28% is implied to come from buybacks — both channels are meaningfully in play. Apt Medical operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHA: 688617 · SSE: 688617 · 688617
Want the full picture on whether Apt Medical (688617.SH) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 37.80 | ||||||
| P/B (MRQ) | 11.40 | ||||||
| P/S (TTM) | 11.60 | ||||||
| Dividend Yield | 0.39% | ||||||
| Buyback + Div Yield | 0.68% |